20251103 - Prof Thomas Seyfried
Dr. Thomas Seyfried on Cancer as a Metabolic Disease: Rethinking Treatment Through Ketogenic Therapy
What if everything we thought we knew about cancer was fundamentally wrong? Dr. Thomas Seyfried's unexpected journey from epilepsy research to cancer metabolism reveals a startling possibility—that cancer might be a metabolic disease rather than a genetic one.
Dr. Thomas Seyfried, a geneticist and pioneer in metabolic cancer research, challenging conventional oncology with groundbreaking evidence that cancer is fundamentally a mitochondrial metabolic disorder, not a genetic disease.
Dr. Seyfried reveals how dysfunctional mitochondria force cancer cells into ancient fermentation pathways, making them dependent on glucose and glutamine while starving them of oxygen-based energy. His research demonstrates that nutritional ketosis—lowering blood glucose while increasing ketone bodies—can selectively restrict tumor growth without harming healthy cells.
Key Takeaways:
- Cancer may be primarily a metabolic disease, not a genetic one
- Seyfried's research challenges the dominant genetic theory of cancer, suggesting dysfunctional mitochondria and altered metabolism are the root cause rather than genetic mutations.
- Ancestral diet patterns hold modern cancer solutions
- Ketosis and paleolithic-style metabolism may be therapeutic tools for cancer because they starve tumors of their preferred fuel (glucose) while keeping healthy cells intact.
- Hits: 184